Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
20.06.2019 18:54:07

DGAP-PVR: Elanix Biotechnologies AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Elanix Biotechnologies AG
Elanix Biotechnologies AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.06.2019 / 18:54
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: Elanix Biotechnologies AG
Street: c/o Frankfurt, Hanauer Landstrasse 291 B
Postal code: 60314
City: Frankfurt am Main
Germany
Legal Entity Identifier (LEI): 391200SYNFFL0NPAJK90

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Termination of the voting right agreement

3. Details of person subject to the notification obligation
Natural person (first name, surname): Lee Ann Laurent-Applegate
Date of birth: 07 Aug 1962
Legal entity: Elanix
City of registered office, country: Frankfurt am Main, Germany

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
18 Dec 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 Total of both in %
(7.a. + 7.b.)		 Total number of voting rights pursuant to Sec. 41 WpHG
New 12.85 % 0 % 12.85 % 8.080.902
Previous notification 19.35 % 0 % 19.35 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)		 Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)
DE000A0WMJQ4 1038609 0 12.85 % 0 %
Total 1038609 12.85 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
  Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
 

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
20 Jun 2019


20.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Elanix Biotechnologies AG
c/o Frankfurt, Hanauer Landstrasse 291 B
60314 Frankfurt am Main
Germany
Internet: www.elanixbiotechnologies.com

 
End of News DGAP News Service

826591  20.06.2019 

fncls.ssp?fn=show_t_gif&application_id=826591&application_name=news&site_id=smarthouse

Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu Elanix Biotechnologies AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Elanix Biotechnologies AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Börse aktuell - Live Ticker

ATX und DAX schließen schwächer -- Asiens Märkte letztlich überwiegend fester
Der heimische Markt sowie der deutsche Leitindex gaben zur Wochenmitte nach. An den Märkten in Fernost ging es am Mittwoch mehrheitlich nach oben.

Nachrichten

Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen